181 related articles for article (PubMed ID: 16337280)
1. The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins.
van Herwaarden AE; Schinkel AH
Trends Pharmacol Sci; 2006 Jan; 27(1):10-6. PubMed ID: 16337280
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk.
van Herwaarden AE; Wagenaar E; Karnekamp B; Merino G; Jonker JW; Schinkel AH
Carcinogenesis; 2006 Jan; 27(1):123-30. PubMed ID: 16000399
[TBL] [Abstract][Full Text] [Related]
3. Role of the breast cancer resistance protein (ABCG2) in drug transport.
Mao Q; Unadkat JD
AAPS J; 2005 May; 7(1):E118-33. PubMed ID: 16146333
[TBL] [Abstract][Full Text] [Related]
4. The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk.
Jonker JW; Merino G; Musters S; van Herwaarden AE; Bolscher E; Wagenaar E; Mesman E; Dale TC; Schinkel AH
Nat Med; 2005 Feb; 11(2):127-9. PubMed ID: 15685169
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion.
Merino G; Alvarez AI; Pulido MM; Molina AJ; Schinkel AH; Prieto JG
Drug Metab Dispos; 2006 Apr; 34(4):690-5. PubMed ID: 16434544
[TBL] [Abstract][Full Text] [Related]
6. The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin.
Merino G; Jonker JW; Wagenaar E; van Herwaarden AE; Schinkel AH
Mol Pharmacol; 2005 May; 67(5):1758-64. PubMed ID: 15709111
[TBL] [Abstract][Full Text] [Related]
7. Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs.
Breedveld P; Beijnen JH; Schellens JH
Trends Pharmacol Sci; 2006 Jan; 27(1):17-24. PubMed ID: 16337012
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
Leslie EM; Deeley RG; Cole SP
Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415
[TBL] [Abstract][Full Text] [Related]
9. Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): influence of flavonoids and role in milk secretion in sheep.
Pulido MM; Molina AJ; Merino G; Mendoza G; Prieto JG; Alvarez AI
J Vet Pharmacol Ther; 2006 Aug; 29(4):279-87. PubMed ID: 16846465
[TBL] [Abstract][Full Text] [Related]
10. Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice.
Vlaming ML; Lagas JS; Schinkel AH
Adv Drug Deliv Rev; 2009 Jan; 61(1):14-25. PubMed ID: 19118589
[TBL] [Abstract][Full Text] [Related]
11. Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk.
van Herwaarden AE; Wagenaar E; Merino G; Jonker JW; Rosing H; Beijnen JH; Schinkel AH
Mol Cell Biol; 2007 Feb; 27(4):1247-53. PubMed ID: 17145775
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ABCG2).
Meyer zu Schwabedissen HE; Kroemer HK
Handb Exp Pharmacol; 2011; (201):325-71. PubMed ID: 21103975
[TBL] [Abstract][Full Text] [Related]
13. A model of secreting murine mammary epithelial HC11 cells comprising endogenous Bcrp/Abcg2 expression and function.
Tallkvist J; Yagdiran Y; Danielsson L; Oskarsson A
Cell Biol Toxicol; 2015 Apr; 31(2):111-20. PubMed ID: 25791223
[TBL] [Abstract][Full Text] [Related]
14. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.
Natarajan K; Xie Y; Baer MR; Ross DD
Biochem Pharmacol; 2012 Apr; 83(8):1084-103. PubMed ID: 22248732
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer resistance protein in pharmacokinetics and drug-drug interactions.
Xia CQ; Yang JJ; Gan LS
Expert Opin Drug Metab Toxicol; 2005 Dec; 1(4):595-611. PubMed ID: 16863427
[TBL] [Abstract][Full Text] [Related]
16. Assessment of ABCG2-mediated transport of xenobiotics across the blood-milk barrier of dairy animals using a new MDCKII in vitro model.
Wassermann L; Halwachs S; Baumann D; Schaefer I; Seibel P; Honscha W
Arch Toxicol; 2013 Sep; 87(9):1671-82. PubMed ID: 23652544
[TBL] [Abstract][Full Text] [Related]
17. Determinants of the activity and substrate recognition of breast cancer resistance protein (ABCG2).
Szafraniec MJ; Szczygieł M; Urbanska K; Fiedor L
Drug Metab Rev; 2014 Nov; 46(4):459-74. PubMed ID: 25036722
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer resistance protein (BCRP/ABCG2).
Staud F; Pavek P
Int J Biochem Cell Biol; 2005 Apr; 37(4):720-5. PubMed ID: 15694832
[TBL] [Abstract][Full Text] [Related]
19. ABCG2 -- a transporter for all seasons.
Sarkadi B; Ozvegy-Laczka C; Német K; Váradi A
FEBS Lett; 2004 Jun; 567(1):116-20. PubMed ID: 15165903
[TBL] [Abstract][Full Text] [Related]
20. Determination of functional ABCG2 activity and assessment of drug-ABCG2 interactions in dairy animals using a novel MDCKII in vitro model.
Wassermann L; Halwachs S; Lindner S; Honscha KU; Honscha W
J Pharm Sci; 2013 Feb; 102(2):772-84. PubMed ID: 23192864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
